Noa Biran
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
-
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
- Cancer Treatment and Pharmacology
Papers in
- Hematology 77
- Multiple Myeloma Research and Treatments 74
- Acute Myeloid Leukemia Research 5
-
- Protein Degradation and Inhibitors 39
- Histone Deacetylase Inhibitors Research 6
- Cancer therapeutics and mechanisms 5
- Co-authors
- Ajai Chari (13 shared papers)Sundar Jagannath (12 shared papers)David S. Siegel (46 shared papers)David H. Vesole (41 shared papers)Hearn Jay Cho (9 shared papers)Joshua Richter (11 shared papers)Scott Ely (2 shared papers)Emilia Bagiella (1 shared paper)
- Journals
- Blood (29 papers)Journal of Clinical Oncology (16 papers)Transplantation and Cellular Therapy (4 papers)British Journal of Haematology (2 papers)Current Hematologic Malignancy Reports (2 papers)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Noa Biran
77 papers receiving 420 citations
Peers
Comparison fields: 5 of 64
- Hematology 322
- Oncology 226
- Molecular Biology 256
- Genetics 35
- Family Practice 5
Countries citing papers authored by Noa Biran
This map shows the geographic impact of Noa Biran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noa Biran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noa Biran more than expected).
Fields of papers citing papers by Noa Biran
This network shows the impact of papers produced by Noa Biran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noa Biran. The network helps show where Noa Biran may publish in the future.
Co-authors
The 25 scholars most cited alongside Noa Biran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 30 | |
| 2 | 2023 | 28 | |
| 3 | 2015 | 21 | |
| 4 | Risk stratification in multiple myeloma, part 1: characterization of high-risk disease. | 2013 | 18 |
| 5 | 2014 | 17 | |
| 6 | 2020 | 15 | |
| 7 | 2018 | 14 | |
| 8 | 2019 | 14 | |
| 9 | 2020 | 12 | |
| 10 | 2016 | 12 | |
| 11 | 2021 | 12 | |
| 12 | 2020 | 11 | |
| 13 | 2021 | 10 | |
| 14 | 2016 | 10 | |
| 15 | 2021 | 9 | |
| 16 | 2013 | 9 | |
| 17 | 2018 | 9 | |
| 18 | 2017 | 8 | |
| 19 | 2020 | 8 | |
| 20 | 2024 | 8 |
About Noa Biran
Noa Biran is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Pathology and Forensic Medicine, having authored 89 papers that have together received 427 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (74 papers), Protein Degradation and Inhibitors (39 papers), Peptidase Inhibition and Analysis (15 papers), Cancer Treatment and Pharmacology (14 papers), CAR-T cell therapy research (11 papers), Histone Deacetylase Inhibitors Research (6 papers), Cancer therapeutics and mechanisms (5 papers) and Acute Myeloid Leukemia Research (5 papers). The work is most often cited by research in Hematology (322 citations), Oncology (226 citations), Molecular Biology (256 citations), Genetics (35 citations) and Family Practice (5 citations). Noa Biran has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Ajai Chari, Sundar Jagannath, David S. Siegel, David H. Vesole, Hearn Jay Cho, Joshua Richter, Scott Ely, Emilia Bagiella, Jyoti Malhotra and Andrew L. Pecora. Their work appears in journals such as Blood, Journal of Clinical Oncology, Transplantation and Cellular Therapy, British Journal of Haematology and Current Hematologic Malignancy Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.